Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Brain Neoplasms × Eflornithine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Adenomatous Polyposis Coli 2 Neoplasms 1 Melanoma 1 Glioma 1 Colonic Polyps 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 25 Bevacizumab 13 Radiotherapy 11 Trastuzumab 10 Lomustine 9 Capecitabine 8 paclitaxel-Angiopep-2 conjugate 6 Radiation 5 Nivolumab 5 pembrolizumab 4 icotinib 4 dabrafenib 4 Lapatinib 4 Flucytosine 4 Dianhydrogalactitol 4 Corticotropin-Releasing Hormone 4 Chlorotoxin 4 vocimagene amiretrorepvec 3 tucatinib 3 osimertinib 3 motexafin gadolinium 3 abemaciclib 3 Surgical Procedures, Operative 3 Spermine Synthase 3 Radiosurgery 3 Paclitaxel 3 NVP-BKM120 3 Irinotecan 3 Gefitinib 3 Carboplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02796261 2022-01-21

STELLAR

Orbus Therapeutics, Inc.

Phase 3 Unknown

Astrocytoma, Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡